Impact of study design on the results of continuation studies of antidepressants

Journal of Clinical Psychopharmacology

Volumn 28, Issue 4, 2008, Pages 467-468

  Deshauer, Dorian ^a   Moher, David ^b   Fergusson, Dean ^b  

^a Institute of Mental Health   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO;

CLINICAL RESEARCH; CLINICAL TRIAL; DEPRESSION; DRUG RESEARCH; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; LETTER; OUTCOMES RESEARCH; PRIORITY JOURNAL; RELAPSE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; CLASSIFICATION; METHODOLOGY; NOTE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TIME; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME;

EID: 54449094457     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31817ea9d4     Document Type: Letter

References (7)

1. Zimmerman M, Posternak M, Ruggero C. Impact of study design on the results of continuation studies of antidepressants. J Clin Psychopharmacol. 2007;27:177-181.
2. MacLehose RR, Reeves BC, Harvey IM, et al. Hybrid study designs and RCT variants. Health Technol Assess. 2000;4:57-80.
3. Kopec JA, Abrahamowicz M, Esdaile JM. Randomized discontinuation trials: utility and efficiency. J Clin Epidemiol. 1993;46:959-971.
4. Greenhouse JB, Stangl D, Kupfer DJ, et al. Methodologic issues in maintenance therapy clinical trials. Arch Gen Psychiatry. 1991;48: 313-318.
5. Malinckrodt C, Chuang-Stein C, McSorley P, et al. A case study comparing a randomized withdrawal trial and a double-blind long-term trial for assessing the long-term efficacy of an antidepressant. Pharm Stat. 2007;6:9-22.
6. Montgomery SA, Rasmussen JG, Tanghoj P. A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression. Int Clin Psycho- pharmacol. 1993;8:181-188.
7. Emslie GJ, Heiligenstein JH, Hoog SL, et al. Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psych. 2004;43:1397-1405.